Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


GREY:FRTX - Post by User

Comment by RuudinFranceon Dec 09, 2019 3:16pm
101 Views
Post# 30436939

RE:RE:RE:RE:Condensate was $82.28 today

RE:RE:RE:RE:Condensate was $82.28 today
skiptoggle wrote: Tuco, would you say that you'd love to see impairment charges resulting form $120 condensate if PIPE hedged 90% of production in 2020?  I don' think so.  Also I don't think that impairment charges in general are a good thing.  Can you explain why this would be good for shareholders and to the valuation of the company?

I support the hedging program because it provides stability and that is what PIPE needs in 2020.  The 46% of 2020 is a fair balance between stability and seeing the benefit of an upside.  In terms of revenue lets not forget that ~50% of production is NGL.  So we are looking at an earnings boost on 1/2 of 54% of production based on condensate price.  Also base model prices are for $55 US WTI which is closer to $73 CDN. So yes, we are going to see a benefit from rising condensate, just temper our expectations with the fact that not all production will benefit from the increase.  Conversely we are somewhat sheltered from any downturns.


Tuco110 wrote: Ruud, you keep refering back to the hedging program as a drag on revenue growth. Remember that the hedging is not at base model prices of $70 but closer to $78. You seem to be forgeting that even at hedged prices the company is making more than forecast in their production models. I agree that if condensate prices continue to raise it will result in commodity impairment charges on the financials but those are non cash accounting adjustments that don't affect cashflow. I personally would love to see impaiment charges that account for $120 condensate.



Skiptoggle:
In red: a bit unfair (spoiling for a fight?), as they wouldn't. It's a fun question though.
In blue: agreed.
In green: Any good question deserves an answer.

Tuco:
In blue: No, I don't.
In red: No, they aren't.
In green: What you win on the one hand, is lost on the other. 
                Safety in the more or less 50/50 division.

However, you missed the point of my post.
DD (dude donnyboy) misinforms the board.
What he writes is not true. 
I know he's a jerk but he's an idiot to boot. He just ignores facts/logic/common sense.

Nevertheless,

have fun.

P.S.: Be careful when you reply to Skip's question, but please do.
         Consider: "The cost of loss of face". It's not a very forgiving industry.


<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse